Italy extends cloning ban
This article was originally published in Clinica
The Italian government has extended until June 30 2001 its 1997 ministerial order banning all research into the cloning of humans and, save in exceptional circumstances, of animals. While the research community and government alike have applauded Italy's drive to promote therapeutic cloning, concerns remain over the technology's regulatory framework.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.